{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:41:21Z","timestamp":1752550881954},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.remn.2011.03.008","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T06:17:07Z","timestamp":1327904227000},"page":"3-8","source":"Crossref","is-referenced-by-count":6,"title":["The Role of FDG-PET\/CT in Ovarian Cancer Patients with High Tumor Markers or Suspicious Lesion on Contrast-Enhanced CT in Evaluation of Recurrence and\/or in Determination of Intraabdominal Metastases"],"prefix":"10.1016","volume":"31","author":[{"given":"O.","family":"Sari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ozcan Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kara Gedik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Serdengecti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2011.03.008_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics, 2001","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.remn.2011.03.008_bib0010","first-page":"329","article-title":"Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker","volume":"49","author":"Chang","year":"2002","journal-title":"Neoplasma"},{"key":"10.1016\/j.remn.2011.03.008_bib0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00259-001-0750-9","article-title":"Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose","volume":"29","author":"Torizuka","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.03.008_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/GRF.0b013e3181961625","article-title":"Ovarian cancer: detection and radiologic staging","volume":"52","author":"Shaaban","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.remn.2011.03.008_bib0025","series-title":"PET\/CT in Clinical Practice","author":"Lynch","year":"2007"},{"key":"10.1016\/j.remn.2011.03.008_bib0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2214\/ajr.176.3.1760701","article-title":"Role of chest CT in the follow-up of ovarian adenocarcinoma","volume":"176","author":"Dachman","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.remn.2011.03.008_bib0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2214\/ajr.177.4.1770857","article-title":"Value of chest CT scans in routine ovarian carcinoma follow-up","volume":"177","author":"Sella","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.remn.2011.03.008_bib0040","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00268-004-7461-x","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer","volume":"28","author":"Zanon","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.remn.2011.03.008_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00261-002-0046-y","article-title":"Recurrent ovarian malignancy: patterns and spectrum of imaging findings","volume":"28","author":"Park","year":"2003","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.remn.2011.03.008_bib0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/172460089801300402","article-title":"CA 125 the past and the future","volume":"13","author":"Bast","year":"1998","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.remn.2011.03.008_bib0055","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1200\/JCO.2005.02.2582","article-title":"Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range","volume":"23","author":"Santillan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2011.03.008_bib0060","first-page":"1535","article-title":"Role of tumour markers in monitoring epithelial ovarian cancer","volume":"182","author":"Meyer","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.remn.2011.03.008_bib0065","series-title":"Textbook of Medical Oncology","first-page":"106","article-title":"Gynecological Cancer","author":"Banerjee","year":"2009"},{"key":"10.1016\/j.remn.2011.03.008_bib0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1095-0397(99)00013-8","article-title":"Cost analysis of FDG PET for managing patients with ovarian cancer","volume":"2","author":"Smith","year":"1999","journal-title":"Clin Positron Imaging"},{"key":"10.1016\/j.remn.2011.03.008_bib0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2214\/ajr.182.1.1820227","article-title":"Incremental benefits of FDG positron emission tomography ovarian CT alone for the preoperative staging of ovarian cancer","volume":"182","author":"Yoshida","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.remn.2011.03.008_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/gyno.1993.1272","article-title":"Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)","volume":"51","author":"Hubner","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.remn.2011.03.008_bib0085","first-page":"117","article-title":"The role of 18-F-fluorodeoxyglucose position imaging tomography 18-F-FGD PET in ovarian carcinoma","volume":"9","author":"Schr\u00f6der","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.remn.2011.03.008_bib0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00259-003-1367-y","article-title":"[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma","volume":"31","author":"Kim","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.03.008_bib0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.2332031800","article-title":"Integrated FDG PET\/CT in patients with persistent ovarian cancer: correlation with histologic findings","volume":"233","author":"Sironi","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.remn.2011.03.008_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1525-1438.2006.00471.x","article-title":"Wholebody positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer","volume":"16","author":"Murakami","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.remn.2011.03.008_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1148\/rg.241035078","article-title":"PET-CT in Recurrent Ovarian Cancer: Initial Observations","volume":"24","author":"Pannu","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.remn.2011.03.008_bib0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2006.03.004","article-title":"The impact of PET\/CT in the management of recurrent ovarian cancer","volume":"103","author":"Simcock","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.remn.2011.03.008_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10147-005-0489-6","article-title":"Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer","volume":"10","author":"Takekuma","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.remn.2011.03.008_bib0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00404-010-1404-6","article-title":"Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer","volume":"283","author":"Pan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.remn.2011.03.008_bib0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00259-010-1416-2","article-title":"Clinical value of FDG PET\/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET\/CT on patient management?","volume":"37","author":"Bilici","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.03.008_bib0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejso.2005.02.029","article-title":"18F-FDG PET\/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients","volume":"31","author":"Nanni","year":"2005","journal-title":"EJSO"},{"key":"10.1016\/j.remn.2011.03.008_bib0135","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00259-006-0260-x","article-title":"Role of [18F]FDG PET\/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings","volume":"34","author":"Chung","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.03.008_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","article-title":"Clinical use of combined positron emission tomography and computed tomography (PET\/CT) in recurrent ovarian cancer","volume":"105","author":"Thrall","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698211000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698211000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T01:04:56Z","timestamp":1561251896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698211000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0212698211000735"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2011.03.008","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}